FDA Logo links to FDA home page
Center for Biologics Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Biologics Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

horizontal rule
CBER links to product areas Blood Vaccines Cellular/Gene Therapy Tissue Devices
CBER links Products Industry Healthcare Reading Room Meetings What's New
horizontal rule

Vaccines and Related Biological Products Advisory Committee

horizontal rule

February 20, 2003 Meeting

Date and Time:

The meeting will be held on February 20, 2003; 8:30 a.m. to 4:30 p.m.

Location:

Holiday Inn, 8120 Wisconsin Avenue, Bethesda, MD, 301-652-2000

Contact Person:

Jody G. Sachs, D.P.M., or Denise H. Royster, 301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 12391. Please call the Information Line for up-to-date information on this meeting.

Agenda:

The committee will review and discuss the selection of strains to be included in the influenza virus vaccine for the 2003-2004 season and the intramural research program of the Laboratory of Bacterial Polysaccharides (LBP), Office of Vaccines Research and Review (OVRR).

Oral Presentations:

From approximately 1:00 p.m. to 1:30 p.m., and 2:50 p.m. to 3:20 p.m. oral presentations from the public will be scheduled. Those desiring to make formal oral presentations should notify the contact person before February 4, 2003.

Closed Committee Deliberations:

From 3:00 p.m. to 3:30 p.m. the meeting will be closed to permit discussion where disclosure would constitute a clearly unwarranted invasion of personal privacy (5 U.S.C. 552b (c) (6)).

 

 
horizontal rule